ventolin inhaler 100mcg/aem metered-dose aerosol
glaxo canada inc - salbutamol - metered-dose aerosol - 100mcg - salbutamol 100mcg - selective beta 2-adrenergic agonists
ventolin respirator solution 0.5% wv
glaxosmithkline pte ltd - salbutamol sulphate eqv salbutamol - solution - 0.5% w/v - salbutamol sulphate eqv salbutamol 0.5% w/v
atrovent nasal aerosol 20mcg/aem
boehringer ingelheim (canada) ltd ltee - ipratropium bromide - aerosol - 20mcg - ipratropium bromide 20mcg - antimuscarinics antispasmodics
ventolin 5mg/ml respirator solution
glaxosmithkline uk ltd - salbutamol sulfate - nebuliser liquid - 5mg/1ml
ventolin rotacaps salbutamol (as sulfate) 200 microgram powder for inhalation strip pack
glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 241 microgram (equivalent: salbutamol, qty 200 microgram) - insufflation - excipient ingredients: lactose monohydrate - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.ventolin rotacaps are indicated for the above conditions in those patients unable to use a pressurised aerosol bronchodilator satisfactorily. patients most likely to benefit from the use of rotacaps are: 1. children from 3 to 6 years of age who are too young to operate a metered aerosol. 2. patients who have difficulty synchronising deep inhalation with actuation of a metered aerosol. 3. patients who are sensitive to freon propellants.
albuterol sulfate hfa- albuterol sulfate aerosol, metered
h.j. harkins company, inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - 1.1 bronchospasm albuterol sulfate hfa inhalation aerosol is indicated for the treatment or prevention of bronchospasm in patients aged 4 years and older with reversible obstructive airway disease. 1.2 exercise-induced bronchospasm albuterol sulfate hfa is indicated for the prevention of exercise-induced bronchospasm in patients aged 4 years and older. albuterol sulfate hfa is contraindicated in patients with a history of hypersensitivity to any of the ingredients [see warnings and precautions (5.6), description (11)]. 8.1 pregnancy teratogenic effects: pregnancy category c. there are no adequate and well-controlled trials with albuterol sulfate hfa or albuterol sulfate in pregnant women. during worldwide marketing experience, various congenital anomalies, including cleft palate and limb defects, have been reported in the offspring of patients being treated with albuterol. some of the mothers were taking multiple medications during their pregnancies. no consistent pattern of defects can be discerned, and a re
ventolin injection
glaxo smith kline (israel) ltd - salbutamol as sulfate - solution for injection - salbutamol as sulfate 0.5 mg/ml - salbutamol - salbutamol - ventolin injection is indicated in adults.ventolin injection provides short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. it is indicated for the relief of severe bronchospasm.
ventolin syrup salbutamol 2mg/5ml (as sulfate) sugar free oral liquid bottle
glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 0.48 mg/ml (equivalent: salbutamol, qty 0.4 mg/ml) - oral liquid - excipient ingredients: sodium benzoate; hypromellose; citric acid monohydrate; sodium chloride; purified water; sodium citrate dihydrate; saccharin sodium; flavour - indications as at 14 february 2005: ventolin is indicated for the prevention and relief of bronchospasm in bronchial asthma of all types and for the alleviation of any reversible airways obstruction associated with conditions such as chronic bronchitis or emphysema.
ventolin respirator solution
glaxosmithkline inc - salbutamol (salbutamol sulfate) - solution - 5mg - salbutamol (salbutamol sulfate) 5mg - selective beta 2-adrenergic agonists
apo-fluticasone hfa aerosol, metered dose
apotex inc - fluticasone propionate - aerosol, metered dose - 50mcg - fluticasone propionate 50mcg